Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

Published:2020-02 Issue:2 Volume:7 Page:e157-e167
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Penack Olaf,Marchetti Monia,Ruutu Tapani,Aljurf Mahmoud,Bacigalupo Andrea,Bonifazi Francesca,Ciceri Fabio,Cornelissen Jan,Malladi Ram,Duarte Rafael F,Giebel Sebastian,Greinix Hildegard,Holler Ernst,Lawitschka Anita,Mielke Stephan,Mohty Mohamad,Arat Mutlu,Nagler Arnon,Passweg Jakob,Schoemans Hélène,Socié Gerard,Solano Carlos,Vrhovac Radovan,Zeiser Robert,Kröger Nicolaus,Basak Grzegorz W

Funder

ERC

Publisher

Elsevier BV

Subject

Hematology

Reference73 articles.

1. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice;Ruutu;Bone Marrow Transplant,2014

2. The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis;Ruutu;Bone Marrow Transplant,2017

3. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium;Harris;Biol Blood Marrow Transplant,2016

4. The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial;Schoemans;Haematologica,2018

5. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment;Schoemans;Bone Marrow Transplant,2018

Cited by 300 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation;Bone Marrow Transplantation;2024-02-06

2. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation;The Lancet Haematology;2024-02

3. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status;Transplantation and Cellular Therapy;2024-02

4. Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner;Transplantation and Cellular Therapy;2024-02

5. Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease;Journal of Health Economics and Outcomes Research;2024-02-01